Gemcitabine HCL Market to Witness an Outstanding Growth During 2019-2030 : Eli Lilly and Company, Teva Pharmaceutical Industries Ltd
Market Industry Reports (MIR) has published a new report titled “Gemcitabine HCL Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global gemcitabine HCL Market is estimated to be over US$ 680 Million in 2018. It is anticipated to grow at a substantial CAGR from 2019 to 2030.
View full press release